A double-blind, placebo-controlled investigation of the effects of fexofenadine, loratadine and promethazine on cognitive and psychomotor function.
about
Updosing of Nonsedating Anti-histamines in Recalcitrant Chronic UrticariaCentral nervous system effects of the second-generation antihistamines marketed in Japan--review of inter-drug differences using the proportional impairment ratio (PIR)-Antihistamines: models to assess sedative properties, assessment of sedation, safety and other side-effects.Central effects of fexofenadine and cetirizine: measurement of psychomotor performance, subjective sleepiness, and brain histamine H1-receptor occupancy using 11C-doxepin positron emission tomography.Next generation antihistamines: therapeutic rationale, accomplishments and advances.Review of fexofenadine in the treatment of chronic idiopathic urticaria.Sedation and antihistamines: a review of inter-drug differences using proportional impairment ratios.Emerging safety issues regarding long-term usage of H(1)receptor antagonists.Effects of single therapeutic doses of promethazine, fexofenadine and olopatadine on psychomotor function and histamine-induced wheal- and flare-responses: a randomized double-blind, placebo-controlled study in healthy volunteersA study of potential pharmacokinetic and pharmacodynamic interactions between dextromethorphan/quinidine and memantine in healthy volunteers.Fexofenadine hydrochloride in the treatment of allergic disease: a reviewPharmacological rationale for the treatment of chronic urticaria with second-generation non-sedating antihistamines at higher-than-standard doses.Medications influencing central cholinergic neurotransmission affect saccadic and smooth pursuit eye movements in healthy young adults.Brain histamine H1 receptor occupancy of orally administered antihistamines, bepotastine and diphenhydramine, measured by PET with 11C-doxepinLack of effect of single and repeated doses of levocetirizine, a new antihistamine drug, on cognitive and psychomotor functions in healthy volunteers.A comparison of once daily fexofenadine versus the combination of montelukast plus loratadine on domiciliary nasal peak flow and symptoms in seasonal allergic rhinitis.An evaluation of the effects of high-dose fexofenadine on the central nervous system: a double-blind, placebo-controlled study in healthy volunteers.Decreased histamine H1 receptor binding in the brain of depressed patients.A combined neurophysiological and behavioural study into the stimulating effects of fexofenadine on performance.Comparative trial of tramadol/paracetamol and codeine/paracetamol combination tablets on the vigilance of healthy volunteers.A simulated car-driving study on the effects of acute administration of levocetirizine, fexofenadine, and diphenhydramine in healthy Japanese volunteers.Evaluation of the effects of anti-motion sickness drugs on subjective sleepiness and cognitive performance of healthy males.Critical flicker frequency for quantification of low-grade hepatic encephalopathy.Effects of levocetirizine and diphenhydramine on regional glucose metabolic changes and hemodynamic responses in the human prefrontal cortex during cognitive tasks.
P2860
Q26747012-5DB7E225-6485-42CA-AF7D-DC19F7A9EDEDQ28542698-1A885BD0-7AFF-4CD9-910B-6408B63B1D86Q33709795-CD8BD605-43D4-4C0E-B179-1BA91F9AFBEEQ34337549-DAE5E941-0601-4FF1-925C-523021651C90Q34660867-E13AE8C9-569B-4D26-AAE9-835F1D6665A4Q34975901-CA83FBEF-A66B-4C74-AEBF-9535F28C83E1Q34982550-CD26DA7B-FFF6-42D9-B7A2-FA17A496FC60Q35194475-B0F5317A-CC72-4B48-869E-02BE1569D921Q35904482-9E2FE3D9-29F0-4966-BA84-70657CDE896FQ37021521-12502EB1-2F46-4A27-8B44-7D26F57FDA97Q37857671-D6589880-F7B6-43B3-9DB2-6A70D0BB2CC1Q37907381-D3DC668F-0750-4645-92A5-F97010194A9FQ39348593-5059F686-08DB-4AD0-AE0D-AB438F542FC0Q40943347-C4D8CD7E-A09B-4B60-94A3-53E6D2CEBBCEQ42015392-7710865B-B53D-4E75-A8D1-253CDA9902BFQ43987754-ED9BC548-F7DF-485A-9477-CF321BFAF22FQ43987756-4738BF67-B7A7-423E-B4E7-1EF026F6F946Q44980286-61642595-D0F9-4333-BBDA-23D9A994AA6FQ46713303-FC070C75-B6D9-4073-9F08-3A72465D2F78Q46824214-A8DA6F0C-5F40-4CA8-A31A-92AE149AC332Q47450319-394DF6BB-FAF9-4879-BB21-74F0888A8D27Q48136747-44C77221-21D6-49EF-9D63-4DAA61E61987Q51960052-5CEFF63A-AED1-4FA9-A6C4-D953A823F171Q52658852-10F303D2-8840-4368-B6A0-64927730EBEC
P2860
A double-blind, placebo-controlled investigation of the effects of fexofenadine, loratadine and promethazine on cognitive and psychomotor function.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
1999年论文
@zh
1999年论文
@zh-cn
name
A double-blind, placebo-contro ...... tive and psychomotor function.
@ast
A double-blind, placebo-contro ...... tive and psychomotor function.
@en
type
label
A double-blind, placebo-contro ...... tive and psychomotor function.
@ast
A double-blind, placebo-contro ...... tive and psychomotor function.
@en
prefLabel
A double-blind, placebo-contro ...... tive and psychomotor function.
@ast
A double-blind, placebo-contro ...... tive and psychomotor function.
@en
P2093
P2860
P1476
A double-blind, placebo-contro ...... tive and psychomotor function.
@en
P2093
D B Fairweather
I Hindmarch
P2860
P304
P356
10.1046/J.1365-2125.1999.00993.X
P407
P577
1999-08-01T00:00:00Z